Prostaglandin analogues are synthetic ingredients designed to bind to specific prostaglandin receptor sites on cells which then initiate certain types of cellular activity. When it comes to treating glaucoma and the potential for prostaglandin analogues to stimulate eyelash growth, the three of the most well known options are bimatoprost, travoprost, and latanoprost. Among these, bimatoprost (Latisse) is the most well-researched for eyelash growth, though all have the same potential benefits and side effects. To date, systemic side effects have not been reported in the clinical literature.
(Sources: European Journal of Dermatology, November-December 2009, pages 586–587; Experimental Eye Research, April 2009, pages 786–791; Survey of Ophthalmology, November 2008, pages S93–S105; Expert Opinion on Drug Safety, January 2007, pages 45–52; Clinical and Experimental Ophthalmology, November 2006, pages 755–764; and Drugs in Aging, Volume 19, 2002, pages 231–248).
Allergan is currently testing bimatoprost as a potential treatment for scalp hair loss, male and female pattern baldness, otherwise known as androgenetic alopecia. At Bauman Medical Group, we have used latisse/bimatoprost as an 'off label' topical treament for hair regrowth on the scalp and eyebrows with good success, as recently reported by the New York Times.